Different strengths – different ISV? [Power / Sample Size]

posted by mittyri  – Russia, 2014-12-21 19:04 (3834 d 03:48 ago) – Posting: # 14127
Views: 10,607

Dear All,

Are there any "rules of thumb" about the ISV prediction for a study with a new strength?
For exapmle, the formulation 50mg is registered and we're going to conduct the study with the formulation 100 mg.
The drug has linear PK to 120 mg according to the literature.
Could we plan our study with ISV derived from the previous data? Is it safe enough?
Thanks in advance!

Kind regards,
Mittyri

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,674 registered users;
45 visitors (0 registered, 45 guests [including 9 identified bots]).
Forum time: 23:52 CEST (Europe/Vienna)

Complex, statistically improbable things are by their nature
more difficult to explain than
simple, statistically probable things.    Richard Dawkins

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5